We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01179217
Brief Title: A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia

First Submitted : May 21, 2010
First Submitted that Met QC Criteria : August 9, 2010
First Posted : August 11, 2010 (Estimate)

Results First Submitted : December 14, 2016
Results First Submitted that Met QC Criteria : August 8, 2017
Results First Posted : August 10, 2017

Last Update Submitted : August 8, 2017
Last Update Submitted that Met QC Criteria : August 8, 2017
Last Update Posted : August 10, 2017